Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Springworks Therapeutics Inc (SWTX)

Springworks Therapeutics Inc (SWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Springworks Therapeutics Inc 100 WASHINGTON BOULEVARD STAMFORD CT 06902 USA

www.springworkstx.com Employees: 305 P: 203-883-9490

Description:

SpringWorks Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company's product pipeline consists of Nirogacestat and Mirdametinib which are in clinical stage. SpringWorks Therapeutics Inc. is based in Stamford, United States.

Key Statistics

Overview:

Market Capitalization, $K 2,785,012
Enterprise Value, $K 2,608,962
Shares Outstanding, K 74,386
Annual Sales, $ 5,450 K
Annual Net Income, $ -325,100 K
Last Quarter Sales, $ 49,300 K
Last Quarter Net Income, $ -53,530 K
EBIT, $ -300,280 K
EBITDA, $ -298,610 K
60-Month Beta 0.79
% of Insider Shareholders 7.61%
Float, K 68,725
% Float 92.39%
Short Volume Ratio 0.35

Growth:

1-Year Return 71.63%
3-Year Return -45.33%
5-Year Return 64.14%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.72 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -3.88
EPS Growth vs. Prev Qtr -33.33%
EPS Growth vs. Prev Year 43.31%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SWTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -48.21%
Return-on-Assets % -42.19%
Profit Margin % -5,965.14%
Debt/Equity 0.00
Price/Sales 517.98
Price/Cash Flow N/A
Price/Book 5.29
Book Value/Share 7.17
Interest Coverage -0.65
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar